Ansarada Group Ltd
ASX:AND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ansarada Group Ltd
ASX:AND
|
AU |
|
R
|
Rekatech Capital Bhd
KLSE:REKATECH
|
MY |
|
Intesa Sanpaolo SpA
MIL:ISP
|
IT |
|
ASML Holding NV
MIL:1ASML
|
NL |
|
Filana Therapeutics, Inc
NASDAQ:FLNA
|
US |
|
Nongfu Spring Co Ltd
F:7NF
|
CN |
|
Hims & Hers Health Inc
F:82W
|
US |
|
H
|
Haverty Furniture Companies Inc
F:25F
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AND's stock price target?
Not Available
AND does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Ansarada Group Ltd?
Projected CAGR
20%
Over the last 6 years, the compound annual growth rate for Revenue has been 109%. The projected CAGR for the next 2 years is 20%.